1302. Development of B Lineage Specific Lentiviral Vectors for Use in Gene Therapy of Human B Lymphocyte Disorders

"7" "!"!

               D."?!"  

   >(     

        3             >  

           3 

            

   

   G

           >(   

      '  >(         

          3 

              * 3   G

                         -   /        

         3   

                "       

     

         "     

 '  - 8,/  

  

3           ?       

    -  ?!/ 3                                

               >(         '            >(                  "

  

1302. Development of B Lineage Specific Lentiviral Vectors for Use in Gene Therapy of Human B Lymphocyte Disorders Maria I. Garcia-Lloret,1 Keun Chae,1 Ruby Tabuchi,1 Carolyn Lutzko,2 Don Khon,2 David J. Rawlings.1 1 Department of Pediatrics, UCLA, Los Angeles, California, United States; 2Children′s Hospital, Los Angeles, California, United States. 4                " -(*/         

 3      0    

       2                    -C(/        2      '    (*                ?!         

 ' 

7       ?!         3                I 3    2    "     -C2"D / 

      C(I   3     C(  

       2  #.   !A     3 

   -TB 

/ 3                    ->/           

   ?! 3   ="&                  $;5 -  I 2,5/   

3 

     2      3  ' 

 >2,5       

        ?! 3   2  

    3 

         #       

   -  #)/  

 1             &"89         ?!     2                    *2,5   3  

    2   - 2O 2O  2M  2/  C2"D  

    2     >2,5  -

 >!A >#./           ?! 3    -,9"&9H  89",&H/            3  -#? :99"8=99  =99"B99/ C "  

3      2        #J   2    

     8, 

  C2"D  ($% *)$  C( 

             

          

 * 3 

    ?! 3    

    $ 85J  -2   /    >2,5   

             ?!    1  

 

$85J $==J-  /      

     >!A   >#.                    >2,5      

   

    

    3         2                     2    

S426

1303. Optimization of HIV -1 Based Lentiviral V ectors HIV-1 Vectors for Gene-Modification of Leukemia Cells Aaron C. Logan,1, 2 Donald B. Kohn.1, 2 1 Division of Research Immunology/Bone Marrow Transplantation, Childrens Hospital Los Angeles, Los Angeles, CA, United States; 2 Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States. D                    "                                       #                 3             "       E   

                        

 )                              3         0       

   C."8 

                         ##D.

                      G

          "   3                                   -!! /              C."8              

                                   "    3            !!                                          "    3           !!                                     

   

 #)  !! J  !! "        ?!         G

        8,               

        3      

   !! J          "  3  8,",6      !! "     2                            !!             

         "  3     1                  3           

 

#.                   4=    #!(.                    

  

          

 3     6"8,    2      =",&            ,"=        (                !! &V                           3  -6"8:H   / '

            (.69    D @   

3              -≤&9H   / '          3           0!@>

                

          3  2

                !!    (.69       

   

             3                

1304. T ectors Transcriptional Targeting Vectors ranscriptional T argeting of Lentiviral V TR Enhancer Replacement LTR by L Francesco Lotti,1 Emilio Menguzzato,1 Luigi Naldini,2 Fulvio Mavilio,1 Giuliana Ferrari.1 1 San Raffaele-Telethon Institute for Gene Therapy (HSR-TIGET), Istituto Scientifico H.S.Raffaele, Milano, Italy; 2Institute for Cancer Research and Treatment, University of Torino Medical School, Torino, Italy.           1            "         -C(/         3          C." 

                    "               "        0   

                     

       D @            "

Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy